LEAH MILLER: Open Payments
NPI 1891807368 · GOSHEN, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,137 in 41 payments from 17 companies in 2025. Trend: 2023 $867 · 2024 $1,205 · 2025 $2,137
Food & beverage: $1,844Travel & lodging: $292
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 3 | $779 |
| ABBVIE INC. | 12 | $442 |
| Axsome Therapeutics, Inc. | 3 | $187 |
| CATALYST PHARMACEUTICALS, INC. | 8 | $141 |
| Otsuka America Pharmaceutical, Inc. | 2 | $140 |
| Lundbeck LLC | 1 | $124 |
| SI-BONE, INC. | 1 | $83 |
| EMD Serono, Inc. | 2 | $38 |
| TG Therapeutics, Inc. | 1 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
Products named: VNS Therapy, QULIPTA, Symbravo, FYCOMPA, REXULTI, VYEPTI, Mavenclad, BRIUMVI.
Industry payments across IN — which companies pay providers there.
